Exercise training induces physical adaptations for heart failure patients with systolic dysfunction but less is known about those patients with preserved ejection fraction. This study's aims were to establish if exercise training produces changes in peak VO 2 and related measures, quality of life, general health and diastolic function in heart failure patients with preserved ejection fraction (HFpEF).
Introduction
Heart Failure with preserved Ejection Fraction (HFpEF) is defined as an inability of the ventricles to optimally accept blood from the atria with blunted end-diastolic volume response by limiting the stroke volume and cardiac output. Exercise intolerance and reduced quality of life are known as the primary chronic symptoms in HFpEF patients. HFpEF prevalence is higher in elderly and women and may be linked to hypertension, diabetes mellitus and atrial fibrillation [1, 2] . Chronic Heart Failure (CHF) patients with either normal or abnormal systolic function have similar mortality rates [3] . In the United States, chronic heart failure affects approximately 5 million individuals with heart failure and over 555,000 are newly diagnosed with CHF annually [4] . Corresponding costs to the health care systems are enormous. A 2011 review by Smart [5] estimated the hospital-based exercise therapy treatment costs to prevent mortality in one systolic heart failure patient to be approximately US$60K per annum. A range of benefits are likely in patients with systolic heart failure undertaking exercise training [6] [7] [8] [9] [10] [11] [12] [13] [14] . Meta-analyses have shown exercise training to be beneficial in HFpEF patients in terms of improved cardio-respiratory fitness [15] [16] [17] .
In people with HFpEF, as well as systolic heart failure, cardiorespiratory fitness (peak VO 2 ) is impaired [18, 19] . Impaired peak VO 2 has been associated with increased mortality risk [20] and decreased quality of life in heart failure patients. As measured by traditional indices such as ejection fraction, systolic function appears largely normal under resting baseline conditions in HFpEF. However, studies have shown through global assessment of systolic function by other techniques, such as strain rate imaging, systolic abnormalities do exist in HFpEF patients [21] . Despite the preservation of systolic function at rest, mortality rates in HFpEF are similar to those observed in systolic failure [22] , highlighting the clear need for effective treatment strategies for these patients.
Interestingly, conventional methods for treating heart failure have proven largely ineffective for HFpEF patients. Currently, effective therapeutic approaches for HFpEF are limited and focus primarily on managing cardiovascular risk factors, especially hypertension. Exercise therapy is a promising effective adjunct therapy that can delay disease progression, minimize pharmaceutical use and improve functional limitations and quality of life. While to date approximately 100 randomized, controlled Review trials of exercise training trials have been published in systolic heart failure patients, strikingly, only 10 such trials exist examining HFpEF [17] .
In this meta-analysis, our purpose was to assess the effects of exercise on a number of outcome measures that are commonly used to assess clinical status in HFpEF. First, we evaluated the impact of exercise training on changes to exercise capacity in HFPEF patients compared to sedentary controls through examination of peak VO 2 , V E /VCO 2 , heart rate, and the 6-min walk test. Second, we studied clinical measures of diastology including early to late filling ratio (E/A), deceleration of early ventricular filling, and E/e' (a widely accepted noninvasive surrogate of left ventricular filling pressure). Third, we examined if exercise training produces better quality of life and/or general health through use of the Minnesota Living with Heart Failure Questionnaire [23] and the SF-36 (which has established norms) [24] . Finally, we examined if rates of serious events, mortality and hospitalization were more frequent with exercise training in HFPEF patients.
Methods

Search strategy
Studies were identified through a MEDLINE search (1985 to September 1, 2015), Cochrane Controlled Trials Registry (1966 to September 1, 2015), CINAHL, SPORTDiscus and Science Citation Index. The search strategy included a mix of MeSH and free text terms for key concepts related to exercise training, heart failure with normal ejection fraction and heart failure with preserved ejection fraction, peak VO 2 and diastolic heart failure for clinical trials of exercise training in heart failure patients. Studies were included if patients exhibited baseline Left Ventricular Ejection Fraction above 45%. These searches were limited to prospective randomized or controlled trials and human studies; with no language restrictions on publications. Manuscript reference lists and latest journal editions were scrutinised for new references. Full journal articles were assessed by three reviewers (NS, GD and HI) for relevance and eligibility. Methodological disagreements were resolved by reviewers through discussion. For two studies [25, 26] , authors were contacted and requested to provide further data about the protocol for implementing desired exercise intensity.
Study selection
Included were randomized controlled designs of exercise training in heart failure patients with normal or preserved ejection fraction. Studies of heart failure patients with abnormal, systolic function were excluded. All included studies are comparisons between exercise training and sedentary control. Records identified 33 papers through database searching. Six additional records from reference lists were added. Only principal studies, with the most subjects, were included where multiple publications existed from the same dataset. After initial screening, 19 studies were removed, which included overlapping, duplicates, duplicate data, abstracts, irrelevant articles (e.g. editorials and discussion papers). We further excluded 12 studies where the control group received additional intervention, non-relevant studies and acute exercise responses. Eight studies of exercise training intervention were included (Consort Statement, Figure 1 ).
Outcomes measures
We recorded the following; peak VO 2 (baseline and post exercise), V E /VCO 2 , maximum heart rate, 6 
Data synthesis
We calculated patient-hours of exercise training and percentage change in peak VO 2 .
Assessment of study quality
We assessed study quality using the 15-point TESTEX scale [27] , which is a validated study quality assessment tool specific to exercise training studies. Median TESTEX score was 10, with two studies scoring 8, three scoring 10 and two studies scoring 12.
Statistical analyses
Revman 5.1 software (The Nordic Cochrane Centre, Copenhagen, Denmark) was used for data analysis. Continuous data were reported as mean and standard deviation. Revman 5.1 enabled calculation of post-intervention change from baseline for standard deviation, using change in mean values, number of subjects and p value or preferably 95% confidence intervals. In many cases where exact p-values were not provided, we used default values e.g. p<0.05 became p=0.049. Mean difference (MD) in these data from baseline were analyzed. We used a 5% level of significance and a 95% confidence interval to report change in outcome measures. Egger plots were produced to identify sources of publication bias [28] .
Results
Included studies
Eight studies met selection criteria [18, 25, 26, [29] [30] [31] [32] [33] , providing a total of 174 exercising subjects and 143 control subjects, a total of 317 participants (Table 1) . Total patient-hours of exercise training reported were 3222 hours. Review pime pime pime pime p pi im me e EDITRICE 
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Change in diastolic function
Change in E/A ratio Data from four studies showed the ration of early diastolic filling (E/A ratio) was significantly improved, MD 0.07 (95% C.I. 0.02 to 0.12, p=0.006) with exercise versus control ( Figure 6 ).
Change E/E' ratio
Data from five studies showed a significant reduction in diastolic filling pressure (E/E' ratio), MD was -2.38 (95% C.I. -3.47 to -1.28, p<0.0001) with exercise versus control (Figure 7 ).
Change in deceleration time
Data from three studies showed a significant reduction in diastolic deceleration time (D T ), MD of -13.2ms (95% C.I. -19.8 to -6.5, p=0.0001) with exercise versus control (Figure 8) .
Change in quality of life
Data from seven studies showed a significant improvement in Minnesota Living with Heart Failure Questionnaire (MLHFQ) score, MD -6.77 units (95% C.I. -9.70 to -3.84, p<0.00001) with exercise versus control ( Figure 9 ).
Change in the Short Form-36 health survey
Data from three studies showed a significant improvement in physical dimension of the Short Form-36 health survey was 11.38 units (95% C.I. 5.28 to 17.48, p=0.0003) with exercise versus control (Figure 10 ).
Exercise training parameters
Program length for high intensity training varied from 6-26 weeks and frequency from 2-5 sessions weekly. Three studies used walking and cycle training, one used only walking, two used cycling only, one used functional electrical stimulation and one inspiratory muscle training.
Outcome measures
Change in peak VO 2 Data from five studies showed a significant improvement in peak VO 2 , mean difference (MD) 2.08 mL kg -1 min -1 (95% C.I. 1.51 to 2.65, p<0.00001) in exercise versus control (Figure 2 ).
Change in peak V E /VCO 2 slope
Data from four studies showed V E /VCO 2 slope was not significantly changed, MD was -3.10 units (95% C.I. -7.47 to 127, p=0.16) in exercise versus control (Figure 3 ).
Change in heart rate
Data from five studies showed maximum heart rate was significantly reduced, MD 3.46 bpm (95% C.I. 2.41 to 4.51, p<0.00001), in exercise versus control (Figure 4 ).
Change in 6-min walk test (6MWT)
Data from four studies for 6-min walk test (6MWT) reported a significant increase in walking distance, MD of 32.1 metres (95% C.I. 17.20 to 47.05, p<0.0001) in exercise versus control ( Figure 5 ). 
Adverse events
All studies reported adverse events; deaths, hospitalizations, and cardiovascular events (Table 2 ). There were no deaths reported from exercise training or control groups in any of the included studies. One hospital admission was reported from an exercise training patient. Overall, there were 3222 patient-hours of exercise training reported. There were insufficient adverse event data to justify analyses.
Study quality
Median TESTex score was 11 out of 15 for all studies (Table 3) . Funnel (Egger) plots of the analysis showed minimal evidence of publication bias.
Heterogeneity
Only the analyses of V E /VCO 2 slope and six minute walk distance showed high heterogeneity. 
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Discussion
This meta-analysis indicates that, in HFpEF patients, the magnitude of gain in cardio-respiratory fitness is similar to that seen in systolic heart failure patients exercising at moderate intensity [6, 7] . In HFpEF, exercise training elicits in improvements in cardiac (diastolic) function, health related quality of life, general health, maximum heart rate and six minute walk distance which complement improvements seen in cardio-respiratory fitness.
Change in peak VO 2 ,V E /VCO 2 slope, maximum heart rate and 6-minute walk distance
The improvements in peak VO 2 observed with exercise training are complemented with changes in maximum heart rate, but not in V E /VCO 2 slope. This current analysis produced peak VO 2 changes of similar effect size seen previously [16] . Although two trials have shown an improvement in V E /VCO 2 slope, our analysis does not identify an improvement with exercise training. A previous meta-analysis did not analyze change in V E /VCO 2 slope in HFpEF patients [16] . A previous report established a strong prognostic relationship between peak VO 2, V E /VCO 2 slope and mortality in heart failure patients with reduced systolic function [34] . Our analysis showed maximum heart rate to be higher after exercise training; the resultant increase in maximal cardiac output would at least partially explain why peak VO 2 improved with training. Although V E /VCO 2 slope did not become lower in our analysis, a reduction would imply improved ventilatory efficiency and would likely contribute to improved cardio-respiratory fitness. A mean 10-12 bpm increase in maximum heart rate after training has been reported in systolic heart failure and HFpEF in previous trials [18, 35] .
Diastolic function
Our analysis of E/A ratio is the first to identify that exercise training may significantly improve this aspect of diastolic function. Neither individual studies, nor pooled analyses published previously have shown a post-exercise training benefit. Our analysis of E/E' confirms the finding of Edelmann et al. [30] but not the findings of the pooled analysis of Taylor et al. [16] . E/E' is a surrogate for filling pressure and our analysis suggests a small reduction (improvement) is elicited with exercise training in HFpEF patients. We suspect that these changes in E/E' do not account for all of the improvement in peak VO 2 , we therefore acknowledge that some changes may be due to improved endothelial function [36] . Deceleration time (D T ) was also significantly reduced in our analysis; this is the first analysis to demonstrate such a benefit. Together these three measures of diastolic function have shown a trend topime pime pime pime p pi im me e EDITRICE Table 3 . Study quality assessment of included studies using the tool for the assessment of study quality in exercise training (TESTEX).
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Conclusions
Exercise training does yield improvements in cardio-respiratory fitness, diastolic function, quality of life and general health in heart failure patients with preserved ejection fraction.
Quality of life and general health
Our analysis showed HFpEF patients exhibited reductions (improvements) in Minnesota Living with Heart Failure scores of similar magnitude to those seen in patients with systolic heart failure [39] . Our analyses also showed HFpEF patients exhibited increased (improved) SF-36 scores. The effect size was of a similar magnitude to improvements seen previously in heart failure patients with normal (HFpEF) and abnormal systolic function [35] .
Limitations
The major limitation of this analysis is that only eight datasets currently exist and associated sample sizes were generally small. In terms of study quality the median TESTEX score for the included studies indicated of good study quality and comprehensive reporting. There were insufficient data to warrant analysis of study withdrawal, adverse events, hospitalization and mortality rates.
Heterogeneity scores indicated the majority of our analyses were justified, but those of V E /VCO 2 slope and 6 MWT may exhibit heterogeneity at levels too high to justify these analyses.
Meta-analysis of continuous data is problematic; for example data sampling duration can alter peak VO 2 values in heart failure [40] . We adjusted for baseline difference in primary outcomes between allocation groups by measuring pre-versus post-intervention change. Often we were accurately able to calculate change in standard deviation, but in cases where exact pvalues were not provided by study reports we used default values e.g. p<0.05 or p<0.001 in our calculations which may introduce errors. Our funnel plots appear to suggest negligible risk of publication bias. We suspect that unpublished datasets with perhaps negative results do not exist.
Finally, we acknowledge that factors related to volume of exercise may explain some of the outcomes reported, for example, intuitively one suspects longer study duration variations may yield better results, but the small number of included studies precluded sub-analyses of exercise volume parameters.
Previous work by one of our authors shows that people with HFpEF tend to typically be 5 or more years older and more likely to be female than their systolic dysfunction counterparts [35] . While the precise volume of screening to identify people with HFpEF for this work were not published, it can be revealed that screening of over 4000 echocardiograms yielded less than 20 exercise training participants. The explanation of this low yield is because for the purposes of scientific rigor, trials of HFpEF need to demonstrate participants do not have ischemic heart disease. Isolation from any hint of ischemic heart disease is rare in HFpEF and therefore makes suitable trial participants extremely difficult to find. This is possibly the primary explanation why over 100 randomized exercise training trials exist in systolic heart failure patients, but only 8 exist to date in HFpEF. 
